CLO buyers seeking longer duration product have a new three-year reinvestment deal from BlackRock to look forward to next week, and it's the second of its kind in the U.S. since the pandemic struck.
The $400 million BSL CLO for BlackRock via Goldman Sachs is slated for Thursday, according to marketing materials reviewed by AlternativesWatch. Investors in CLO new issues have expressed frustration that only PGIM has issued a transaction with a longer than one-year reinvestment period.
Longer reinvestment periods are a hurdle for . . .
Unlock this article instantly, along with the rest of our premium content and daily, weekly and monthly newsletters. We offer pay-as-you-go monthly subscriptions and discounted annual subscriptions with additional benefits: access to Alternatives Watch Research articles and our Annual Investor Compendium.